IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9527807 B1

PDFFull Text
Date of Patent:
Dec. 27, 2016

Filed:

Apr. 05, 2012

Sulfonamide derivative and use thereof

Applicants:

Shoji Fukumoto, Kanagawa, JP;

Osamu Ujikawa, Kanagawa, JP;

Shinji Morimoto, Kanagawa, JP;

Yasutomi Asano, Kanagawa, JP;

Satoshi Mikami, Kanagawa, JP;

Norihito Tokunaga, Kanagawa, JP;

Masakuni Kori, Osaka, JP;

Toshihiro Imaeda, Kanagawa, JP;

Koichiro Fukuda, Kanagawa, JP;

Shinji Nakamura, Kanagawa, JP;

Kouichi Iwanaga, Kanagawa, JP;

Inventors:

Shoji Fukumoto, Kanagawa, JP;

Osamu Ujikawa, Kanagawa, JP;

Shinji Morimoto, Kanagawa, JP;

Yasutomi Asano, Kanagawa, JP;

Satoshi Mikami, Kanagawa, JP;

Norihito Tokunaga, Kanagawa, JP;

Masakuni Kori, Osaka, JP;

Toshihiro Imaeda, Kanagawa, JP;

Koichiro Fukuda, Kanagawa, JP;

Shinji Nakamura, Kanagawa, JP;

Kouichi Iwanaga, Kanagawa, JP;

Assignee:

Takeda Pharmaceutical Company Limited, Osaka, JP;

Attorney:

Hamre, Schumann, Mueller & Larson, P.C.

Primary Examiner:

Kamal Saeed

Int. Cl.
CPC ...
C07C 311/07 (2006.01); C07D 401/12 (2006.01); C07D 309/14 (2006.01); C07D 295/092 (2006.01); C07D 333/16 (2006.01); C07D 231/12 (2006.01); C07D 211/58 (2006.01); C07C 311/09 (2006.01); C07C 311/14 (2006.01); C07C 317/28 (2006.01); C07C 323/26 (2006.01); C07D 209/04 (2006.01); C07D 213/64 (2006.01); C07D 231/14 (2006.01); C07D 233/68 (2006.01); C07D 261/08 (2006.01); C07D 263/32 (2006.01); C07D 277/24 (2006.01); C07D 277/62 (2006.01); C07D 307/22 (2006.01); C07D 405/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 405/14 (2006.01); C07D 309/06 (2006.01); C07D 213/85 (2006.01); C07D 401/04 (2006.01); C07D 237/04 (2006.01); C07D 239/28 (2006.01); C07D 409/12 (2006.01); C07D 493/08 (2006.01); C07D 207/27 (2006.01); C07D 207/273 (2006.01); C07D 277/32 (2006.01); C07D 211/56 (2006.01); C07D 211/76 (2006.01); C07D 295/192 (2006.01); C07D 213/61 (2006.01); C07D 305/06 (2006.01); C07D 233/56 (2006.01);
U.S. Cl.
CPC ...
C07C 311/07 (2013.01); C07C 311/09 (2013.01); C07C 311/14 (2013.01); C07C 317/28 (2013.01); C07C 323/26 (2013.01); C07D 207/27 (2013.01); C07D 207/273 (2013.01); C07D 209/04 (2013.01); C07D 211/56 (2013.01); C07D 211/58 (2013.01); C07D 211/76 (2013.01); C07D 213/61 (2013.01); C07D 213/64 (2013.01); C07D 213/85 (2013.01); C07D 231/12 (2013.01); C07D 231/14 (2013.01); C07D 233/56 (2013.01); C07D 233/68 (2013.01); C07D 237/04 (2013.01); C07D 239/28 (2013.01); C07D 261/08 (2013.01); C07D 263/32 (2013.01); C07D 277/24 (2013.01); C07D 277/32 (2013.01); C07D 277/62 (2013.01); C07D 295/092 (2013.01); C07D 295/192 (2013.01); C07D 305/06 (2013.01); C07D 307/22 (2013.01); C07D 309/06 (2013.01); C07D 309/14 (2013.01); C07D 333/16 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 493/08 (2013.01); C07C 2101/02 (2013.01); C07C 2101/08 (2013.01); C07C 2101/14 (2013.01); C07C 2103/74 (2013.01);
Abstract

Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. A compound represented by the formula (I): wherein each symbol is as defined in the present specification,or a salt thereof.

Find Patent Forward Citations

Loading…